Next Article in Journal
A Pan-Canadian Prospective Study of Young Women with Breast Cancer: The Rationale and Protocol Design for the RUBY Study
Previous Article in Journal
Strategies for the Delay of Surgery in the Management of Resectable Hepatobiliary Malignancies during the COVID-19 Pandemic
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Musculoskeletal Oncology: Patient Triage and Management during the COVID-19 Pandemic

Division of Orthopedic Surgery, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2020, 27(5), 512-515; https://doi.org/10.3747/co.27.6907
Submission received: 12 July 2020 / Revised: 7 August 2020 / Accepted: 8 September 2020 / Published: 1 October 2020

Abstract

Sarcoma treatment during the covid-19 pandemic is a new challenge. This patient population is often immunocompromised and potentially more susceptible to viral complications. Government guidelines highlight the need to minimize patient exposure to unnecessary hospital visits. However, those guidelines lack practical recommendations on ways to manage triage and diagnosis expressly for new cancer patients. Furthermore, there are no reports on the efficiency of the guidelines. One of the main issues in treating musculoskeletal tumours is the complexity and variability of presentation. We offer a triage model, used in a quaternary-referral musculoskeletal oncology centre, that allows us to maintain an open pathway for referral of new patients while minimizing exposure risks. A multidisciplinary approach and analysis of existing investigations allow for a pre-clinic evaluation. The model identifies 3 groups of patients: (1) Patients with suspected high-grade malignancy, or benign cases with aggressive features, both in need of further evaluation in the clinic and prompt treatment; (2) Patients with low-grade malignancy, and benign cases whose treatment is not urgent, that are managed during the pandemic by telemedicine, with reassurance and information about their illness; (3) Patients who can be managed by their local medical professionals. In comparison to a pre-pandemic period, that approach resulted in a higher ratio of malignant-to-benign conditions for new patients seen in the clinic (3:4 vs. 1:3 respectively), thus using available resources more efficiently and prioritizing patients with suspected high-grade malignancy. We believe that this triage system could be applied in other surgical oncology fields during a pandemic.
Keywords: sarcoma; orthopedic oncology; musculoskeletal tumours; covid-19 pandemic sarcoma; orthopedic oncology; musculoskeletal tumours; covid-19 pandemic

Share and Cite

MDPI and ACS Style

Olshinka, N.; Mottard, S. Musculoskeletal Oncology: Patient Triage and Management during the COVID-19 Pandemic. Curr. Oncol. 2020, 27, 512-515. https://doi.org/10.3747/co.27.6907

AMA Style

Olshinka N, Mottard S. Musculoskeletal Oncology: Patient Triage and Management during the COVID-19 Pandemic. Current Oncology. 2020; 27(5):512-515. https://doi.org/10.3747/co.27.6907

Chicago/Turabian Style

Olshinka, N., and S. Mottard. 2020. "Musculoskeletal Oncology: Patient Triage and Management during the COVID-19 Pandemic" Current Oncology 27, no. 5: 512-515. https://doi.org/10.3747/co.27.6907

APA Style

Olshinka, N., & Mottard, S. (2020). Musculoskeletal Oncology: Patient Triage and Management during the COVID-19 Pandemic. Current Oncology, 27(5), 512-515. https://doi.org/10.3747/co.27.6907

Article Metrics

Back to TopTop